Journals / Annals of Medical Research / 2020 / Cilt: 27 - Sayı: 3

Clinicopathologic features of operated gastric cancer patients, single center nine years experience

Pages
864–869
Publication Date
2022-10-12
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Data including clinicopathologic features, postoperativecomplications, overall survival and prognostic factors affecting prognosis were analyzed and statistical analysis was performed.Data including clinicopathologic features, postoperative complications, overal survival and prognostic factors affecting prognosiswere analyzed and statistical analysis was performed.Results: Of the patients, 134 (67%) were males and 66 (33%) were females.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: Gastric cancer is one of most common malignancies in the world.
📊
Key Findings & Data:In this study, we aimed todescribe clinicopathological characteristics and outcomes of gastric cancer in patients who were operated in our clinic.Material and Methods: We respectively evaluated a total of 200 patients who underwent gastrectomy, D2 lymph node dissectiondue to gastric cancer between November 2006 and December 2015.
💡
Conclusion & Impact:Data including clinicopathologic features, postoperativecomplications, overall survival and prognostic factors affecting prognosis were analyzed and statistical analysis was performed.Data including clinicopathologic features, postoperative complications, overal survival and prognostic factors affecting prognosiswere analyzed and statistical analysis was performed.Results: Of the patients, 134 (67%) were males and 66 (33%) were females.
🔬Design:Research Article
📍Scope:2006 Verileri
⚙️Variables:Domain Parameters

Abstract

Aim: Gastric cancer is one of most common malignancies in the world. In developed countries including Europe and United States,despite the advanced technology, advanced stages of gastric cancer are still common with a poor survival. In this study, we aimed todescribe clinicopathological characteristics and outcomes of gastric cancer in patients who were operated in our clinic.Material and Methods: We respectively evaluated a total of 200 patients who underwent gastrectomy, D2 lymph node dissectiondue to gastric cancer between November 2006 and December 2015. Data including clinicopathologic features, postoperativecomplications, overall survival and prognostic factors affecting prognosis were analyzed and statistical analysis was performed.Data including clinicopathologic features, postoperative complications, overal survival and prognostic factors affecting prognosiswere analyzed and statistical analysis was performed.Results: Of the patients, 134 (67%) were males and 66 (33%) were females. The mean age was 61.36±11.92 (28-91) years. Tumorlocalization was frequently low (57%). The most common postoperative complication, regardless of the type of gastrectomy, wasthe surgical site infection. The major of the patients had Stage 3 disease. The median overall survival was 24.9 (0.07-116.3) monthsand overall survival was 43.7%.Conclusion: Except for early stage, the chance of curative treatment is low in gastric cancer. Early diagnosis and treatment can yieldimproved outcomes for this patient population. Therefore, it is important to develop national programs for early diagnosis and todevelop experienced endoscopists

🔖

Cite This Article

YOL, S., POLAT, E., UZUN, O., SENCER, A. S., DİNCER, M., DUMAN, M., DEGER, K. C., CİGİLTEPE, H., GUNDES, E., CETIN, D. A., ADAY, U. (2022). Clinicopathologic features of operated gastric cancer patients, single center nine years experience. Annals of Medical Research, Cilt: 27 - Sayı: 3, 864–869. https://ajindex.com/articles/446445

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (19)

  1. Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012. CA Cancer J Clin 2015;65:87-108
  2. Forman D, Burley VJ. Gastric cancer: global pattern of the disease and an overview of environmental risk factors. Best Pract Res Clin Gastroenterol 2006;20:633-49
  3. Ferlay J, Shin HR, Bray F, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010;127:2893-917
  4. Song Z, Wu Y, Yang J, et al. Progress in the treatment of advanced gastric cancer. Tumor Biol 2017;39
  5. Kodera Y, Sano T. Japanese gastric cancer treatment guidelines 2014 (ver
  6. Japanese Gastric Cancer Association 1. Gastric Cancer 2014;20
  7. Isobe Y, Nashimoto A, Akazawa K, et al. Gastric cancer treatment in Japan: 2008 annual report of the JGCA nationwide registry. Gastric Cancer 2011;14:301-16
  8. T.C. Halk Sağlığı Kurumu. Türkiye Kanser İstatistikleri 2015. TC Sağlık Bakanl Halk Sağlığı Müdürlüğü. 2018. https://hsgm.saglik.gov.tr/depo/birimler/kanser-db/ istatistik/Turkiye_Kanser_Istatistikleri_2015.pdf
  9. Japanese gastric cancer treatment guidelines 2010 (ver
  10. Japanese Gastric Cancer Association 2011
  11. Oncology (r Bresalier GI, Editor S. Gastric Cancer: How Can We Reduce the Incidence of this Disease? 2016
  12. Degiuli M, Sasako M, Ponti A, et al. Randomized clinical trial comparing survival after D1 or D2 gastrectomy for gastric cancer. Br J Surg 2014;101:23-31
  13. De Steur WO, Hartgrink HH, Dikken JL, et al. Quality control of lymph node dissection in the Dutch Gastric Cancer Trial. Br J Surg 2015;102:1388-93
  14. Songun I, Putter H, Kranenbarg EMK, et al. Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial. Lancet Oncol 2010;11:439-49
  15. Degiuli M, De Manzoni G, Di Leo A, et al. Gastric cancer: Current status of lymph node dissection. World J Gastroenterol 2016;22:2875-93
  16. Brenkman HJ, Haverkamp L, Ruurda JP, et al. (No Title). World J Gastroenterol 2016;22:4041-8
  17. Yokota T, Ishiyama S, Saito T, et al. Lymph node metastasis as a significant prognostic factor in gastric cancer: A multiple logistic regression analysis. Scand J Gastroenterol 2004;39:380-4
  18. Maehara Y, Kakeji Y, Koga T, et al. Therapeutic value of lymph node dissection and the clinical outcome for patients with gastric cancer. Surgery 2002;131:85-91
  19. Hwang JE, Hong JY, Kim JE, et al. Prognostic significance of the concomitant existence of lymphovascular and perineural invasion in locally advanced ga